phosphatidylcholines has been researched along with scutellarin in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (scutellarin) | Trials (scutellarin) | Recent Studies (post-2010) (scutellarin) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 441 | 7 | 309 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | scutellarin (IC50) |
|---|---|---|---|
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Li, WG; Ning, Q; Yu, DN; Zhou, Y | 1 |
1 other study(ies) available for phosphatidylcholines and scutellarin
| Article | Year |
|---|---|
Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Capsules; Cardiovascular Agents; Cholesterol; Drug Delivery Systems; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Liposomes; Male; Particle Size; Permeability; Phosphatidylcholines; Poloxalene; Poloxamer; Rats, Sprague-Dawley | 2014 |